Detalhe da pesquisa
1.
Clinical activity, pharmacokinetics, and pharmacodynamics of oral hypomethylating agents for myelodysplastic syndromes/neoplasms and acute myeloid leukemia: A multidisciplinary review.
J Oncol Pharm Pract
; : 10781552241238979, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38509812
2.
Cost comparison of filgrastim versus pegfilgrastim and pegfilgrastim biosimilars for inpatient prophylaxis of febrile neutropenia.
J Oncol Pharm Pract
; 29(7): 1695-1701, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36544396
3.
Which hematology/oncology patients are high priority for ambulatory clinical pharmacist review? A three-round Delphi survey by the National Comprehensive Cancer Network.
J Oncol Pharm Pract
; 29(8): 1907-1914, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36803319
4.
Expanding Pharmacy Services to the Hemophilia Treatment Center.
Hosp Pharm
; 58(5): 415-419, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37711404
5.
Pharmacy utilization of electronic patient-reported outcomes in oncology populations.
J Oncol Pharm Pract
; 28(8): 1885-1888, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36000299
6.
Description of the role of pharmacist independent double checks during cognitive order verification of outpatient parenteral anti-cancer therapy.
J Oncol Pharm Pract
; 28(2): 381-386, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33611975
7.
Costs associated with United States pharmacopeia compliant infusion clinics.
J Oncol Pharm Pract
; 28(1): 141-148, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34648391
8.
The formulary process for biosimilar additions at a comprehensive cancer center.
J Oncol Pharm Pract
; 28(1): 185-189, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34565230
9.
Coronavirus 2019 work-from-home productivity of inpatient and infusion pharmacists at a comprehensive cancer center.
J Am Pharm Assoc (2003)
; 62(3): 877-882, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34930680
10.
Describing the role of the hematology/oncology clinical pharmacist in health information technology.
J Oncol Pharm Pract
; 27(1): 14-19, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32306889
11.
Development of a tool to allocate inpatient specialized pharmacy resources at a comprehensive cancer center.
J Oncol Pharm Pract
; 26(7): 1686-1694, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32865162
12.
The pharmacist's role in chimeric antigen receptor T cell therapy.
J Oncol Pharm Pract
; 26(7): 1725-1731, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32819199
13.
Front-line use of tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia: Practice considerations.
J Oncol Pharm Pract
; 26(1): 156-174, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31354102
14.
Demonstrating the value of the oncology pharmacist within the healthcare team.
J Oncol Pharm Pract
; 25(8): 1945-1967, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31288634
15.
Development and Implementation of an Oral Oncology Drug Repository Program.
JCO Oncol Pract
; 17(3): e426-e432, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33186084
16.
Effect of a Pharmacist-Driven Monitoring Program and Electronic Health Record on Bleeding Log Completeness and Documentation.
J Manag Care Spec Pharm
; 24(10): 1034-1039, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30247104